In vitro models for assessing antidiabetic activity

Traditional Medicines for Modern Times: Antidiabetic Plants

Volumn , Issue , 2005, Pages 99-116

  Soumyanath, Amala ^a   Srijayanta, Sairavee ^b  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b JOHNSON AND JOHNSON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85056360674     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1201/9781420019001     Document Type: Chapter

References (120)

1. Abesundara KJM, Matsui T and Matusmoto K. Alpha-glucosidase inhibitory activity of some Sri Lanka plant extracts, one of which, Cassia auriculata, exerts a strong antihyperglycemic effect in rats comparable to the therapeutic drug acarbose. J. Agric. Food Chem., 52(9), 2541-2545, 2004.
2. Agius L. Human liver in vitro techniques for metabolic studies, in Ballière’s Clinical Endocrinology and Metabolism, Alberti K, Home P and Taylor R (Eds). London. Ballière Tindall, 1987, 999-1021.
3. Agius L, Peak M and Alberti K. Regulation of glycogen synthesis from glucose and gluconeogenic precursors by insulin in periportal and perivenous rat hepatocytes. Biochem. J., 266, 91-102, 1990.
4. Ahmad F et al. Hypoglycemic activity of Pterocarpus marsupium wood. J. Ethnopharmacol. 35, 71-75, 1991a.
5. Ahmad F et al. Effect of (-)-epicatechin on cAMP content, insulin release and conversion of proinsulin to insulin in immature and mature rat islets in vitro. Ind. J. Exp. Biol., 29, 516-520, 1991b.
6. Al-Habori M and Raman A. Antidiabetic and hypocholesterolemic effects of fenugreek. Phytother. Res., 12, 233-242, 1998.
7. Al-Habori M et al. Effect of fenugreek extracts on intestinal sodium dependent glucose uptake and hepatic glycogen metabolism in vitro. Int. J. Exp. Diabetes Res., 2, 91-99, 2001.
8. Ali H, Raman A and Houghton PJ. α-Amylase inhibition in Malayasian local plants. J. Pharm. Pharmacol., 55(Suppl): S28, 2003.
9. Anderson RA, Brantner JH and Polansky MM. An improved assay for biologically active chromium. J. Agric. Food Chem., 26, 1219-1221, 1978.
10. Arakawa K et al. Actions of a novel antidiabetic thiazolidinedione, T-174 in animal models of non-insulin- dependent diabetes mellitus (NIDDM) and in cultured muscle cells. Br. J. Pharmacol., 12593, 429-436, 1998.
11. Artursson P. Epithelial transport of drugs in cell culture: a model for studying the passive diffusion of drugs over intestinal absorptive Caco-2 cells. J. Pharm. Sci., 79, 476-482, 1990.
12. Audus K et al. The use of cultured epithelial and endothelial cells for drug transport and metabolism studies. Pharm Res., 7, 435-451, 1990.
13. Azizeh BY et al. Topographical amino acid substitution in position 10 of glucagons leads to antagonists/partial agonists with greater binding differences. J. Med. Chem., 39, 2449-2455, 1996.
14. Ball SW et al. A fluorescent compound for glucose uptake measurements in isolated rat myocytes. Can. J. Phys. Pharmacol., 80, 205-209, 2002.
15. Bawden K, Quant J and Raman A. An investigation into the inhibitory effects of plant extracts on a starchñalphañamylase assay. J. Pharm. Pharmacol., 54 (Suppl): S80, 2002.
16. Bawden K et al. Fractionation and characterization of compounds inhibiting α-amylase and their potential as antidiabetic remedies. J. Pharm. Pharmacol., 55(Suppl): S31, 2003.
17. Bergmeyer H and Bernt E. D-glucose determination with glucose oxidase and peroxidase, in Methods of Enzymatic Analysis, 1st ed. Bergmeyer H. (Ed). Academic Press, New York, 1963, 123-130.
18. Bernfeld P. Amylase-αand -β, in Methods in Enzymology, Vol. I, Colowick SP and Kaplan NO (Eds), Academic Press, New York, 1955, 141-158.
19. Berry M and Friend D. High-yield preparation of isolated rat liver parenchymal cells. A biochemical and fine structural study. J. Cell. Biol., 43, 506-520, 1969.
20. Bismut H and Plas C. Pathways of glycogen synthesis from glucose during the glycogenic response to insulin in cultured fetal hepatocytes. Biochem. J., 263, 889-895, 1989.
21. Broadhurst CL, Polansky MM and Anderson RA. Insulin-like biological activity of culinary and medicinal plant aqueous extracts in vitro. J. Agric. Food Chem., 48, 849-852, 2000.
22. Burant et al. Small intestine hexose transport in experimental diabetes. Increased transporter mRNA and protein expression in enterocytes. J. Clin. Invest., 93, 578-585, 1994.
23. Chattopadhyay R, Chattopadhyay R and Maitra S. Possible mechanism of antihyperglycemic effect of Azadirachta indica leaf extract. Part III. Fitoterapia, LXIV, 533-538, 1993.
24. Connell RD. Glucagon antagonists for the treatment of type 2 diabetes. Expert Opin. Therapeutic Patents, 9(6), 701-709, 1999.
25. Day C. Thiazolidinediones: a new class of antidiabetic drugs. Diabet. Med., 16, 179-192, 1999.
26. Edens NK et al. Yeast extract stimulates glucose metabolism and inhibits lipolysis in rat adipocytes in vitro. J. Nutr., 132, 1141-1148, 2002.
27. Farzami B et al. Induction of insulin secretion by a component of Urtica dioica leave extract in perifused Islets of Langerhans and its in vivo effects in normal and streptozotocin diabetic animals. J. Ethnopharmacol., 89(1), 47-53, 2003.
28. +-dependent nutrient absorption in streptozotocintreated chronically diabetic rats. J. Clin. Invest, 79, 1571-1578, 1987.
29. Fedorak RN et al. Altered glucose carrier expression: mechanism of intestinal adaptation during streptozotocininduced diabetic rats. Am. J. Physiol., 261. (Gastrointest. Liver. Physiol., 24) G585-G591, 1991.
30. Fleig W et al. Modulation by a sulfonylurea of insulin-dependent glycogenesis, but not of insulin binding in cultured rat hepatocytes. Diabetes, 33, 285-290, 1984.
31. Fleig W et al. Regulation of insulin binding and glycogenesis by insulin and dexamethasone in cultured rat hepatocytes. Biochim, Biophys. Acta, 847, 352-361, 1985.
32. Fogh J, Fogh J and Orfeo T. H27 cultured human colon cancer cell lines producing tumors in nude mice. J. Natl. Acad. Sci. USA, 59, 221-226, 1977.
33. Gallagher AM et al. The effects of traditional antidiabetic plants on in vitro glucose diffusion. Nutr. Res., 23, 413-424, 2003.
34. Good C, Kramer H and Somogyi M. The determination of glycogen. J. Biol. Chem., 100, 491, 1933.
35. Gomez-Lechon M, Ponsoda X, and Castell J. A microassay for measuring glycogen in 96-well cultured cells. Anal. Biochem., 236, 296-301, 1996.
36. Gray AM, Abdel-Wahab YHA and Flatt PR. The traditional plant treatment, Sambucus nigra (elder), exhibits insulin-like and insulin-releasing actions in vitro. J. Nutr., 130, 15-20, 2000.
37. Gray AM and Flatt P. Pancreatic and extrapancreatic effects of the traditional antidiabetic plant, Medicago sativa (Lucerne). Br. J. Nutr., 78, 325-334, 1997.
38. Gray AM and Flatt P. Actions of the traditional antidiabetic plant, Agrimony eupatoriai (agrimony). Effect on hyperglycemia, cellular glucose metabolism and insulin. Br. J. Nutr., 80, 109-114, 1998a.
39. Gray AM and Flatt P. Insulin-releasing and insulin-like activity of Agaricus campestris (mushroom). J. Endocrinol., 157, 259-266, 1998b.
40. Gray AM and Flatt P. Insulin-releasing and insulin-like activity of the traditional antidiabetic plant Coriandrum sativum (coriander). Br. J. Nutr., 81, 203-209, 1999a.
41. Gray AM and Flatt P. Insulin-secreting activity of the traditional antidiabetic plant Viscum album (mistletoe). J. Endocrinol., 160(3), 409-414, 1999b.
42. Guyton AC and Hall JE. Digestion and absorption in the gastrointestinal tract, in Textbook of Medical Physiology, 10th ed, Guyton AC and Hall JE (Eds). WB Saunders Company, U.K., 2000, 753-763.
43. Guyton AC and Hall JE. Insulin, glucagon and diabetes mellitus, in Textbook of Medical Physiology, 9th ed, Guyton AC and Hall JE (Eds), WB Saunders Company, U.K., 1997, 971-983.
44. Heacock PM et al. Effects of a medical food containing an herbal alpha-glucosidase inhibitor on post-prandial glycemia and insulinemia in healthy adults. J. Am. Dietetic Assoc., 105(1), 65-71, 2005.
45. Hii C and Howell S. Effects of eipcatechin on rat islets of Langerhans. Diabetes, 33, 291-296, 1984.
46. 2+ handling in rat islets of Langerhans. J. Endocrinol., 107, 1-8, 1985.
47. Hikino H et al. Mechanism of hypoglycemic activity of ganoderan B: a glycan of Ganoderma lucidum fruit bodies. Planta Med., 55, 423-428, 1989a.
48. Hikino H et al. Mechanisms of hypoglycemic activity of actonitan A, a glycan from Aconitum carmichaeli roots. J. Ethnopharmacol., 25, 295-304, 1989b.
49. Hilgers A, Conradi R and Burton P. Caco-2 cell monolayers as a model for drug transport across the intestinal mucosa. Pharm Res., 7, 902-910, 1990.
50. Houghton PJ and Raman A. Laboratory Handbook for the Fractionation of Natural Extracts. 1st ed. Chapman & Hall, London, 1998.
51. Imparl-Radosevich J et al. Regulation of PTP-1 and insulin receptor kinase by fractions from cinnamon: implications for cinnamon regulation of insulin signaling. Horm. Res., 50, 177-182, 1998.
52. Kamei R et al. Shikonin stimulates glucose uptake in 3T3-L1 adipocytes via an insulin-independent tyrosine kinase pathway. Biochem. Biophys. Res. Comm., 292, 642-651, 2002.
53. Kanai F et al. Direct demonstration of insulin-induced GLUT4 translocation to the surface of intact cells by insertion of a c-myc epitope into an exofacial GLUT4 domain. J. Biol. Chem., 268(19), 14523-14526, 1993.
54. Kessler M et al. A modified procedure for the rapid preparation of efficiently transporting vesicles from small intestinal brush border membranes. Biochim, Biophys. Acta, 506, 136-154. 1978.
55. Kim H et als. α-Glucosidase inhibitors from Commelina communis. Planta Med., 65, 437-439, 1999.
56. Kimura Y, Okuda H and Arichi S. Effects of the extracts of Ganoderma lucidum on blood glucose level in rats. Planta Med., 4, 290-294, 1988.
57. Kobayashi Y et al. Green tea polyphenols inhibit the sodium-dependent glucose transporter of intestinal epithelial cells by a competitive mechanism. J. Agric. Food Chem., 48(11), 5618-5623, 2000.
58. Komaki E et al. The identification of anti-α-amylase components from olive leaf extracts. Food Sci. Technol. Res., 9(1), 35-39, 2003.
59. Kurukulasuriya R et al. Potential drug targets and progress towards pharmacological inhibition of hepatic glucose production. Curr. Med. Chem., 10, 123-153, 2003.
60. Lau C et al. Evidence for glucose transport inhibitors in Momordica charantia L. Diabetologia, 39(S1), A171, 1996.
61. Lebovitz H. Oral antidiabetic agents: the emergence of α-glucosidase inhibitors. Drugs, 44, 21-28, 1992.
62. Lewis B and Smith F. Sugars and derivatives, in Thin Layer Chromatography: a Laboratory Handbook, 2nd ed, Stahl E (Ed), George Allen & Unwin Ltd, London, 1969.
63. Li YM et al. Increasing the throughput and productivity of Caco-2 permeability assays using liquid chromatography-mass spectrometry: application to resveratrol absorption and metabolism. Combinatorial Chem. High Throughput Scr., 6(8), 757-767, 2003.
64. Liu F et al. An extract of Lagerstroemia speciosa L. has insulin-like glucose uptake-stimulatory and adipocyte differentiation-inhibitory activities in 3T3-L1 cells. J. Nutr., 131, 2242-2247, 2001.
65. Luo J et al. Cryptolepis sanguinolenta: an ethnobotanical approach to drug discovery and the isolation of a potentially useful new antihyperglycemic agent. Diabet. Med., 15(5), 367-374, 1998.
66. Matsuda H et al. Antidiabetic principles of natural medicines. IV. Aldose reductase and alpha-glucosidase inhibitors from the roots of Salacia oblonga Wall. (Celastraceae): structure of a new friedelane-type triterpene, kotalagenin 16-acetate. Chem. Pharm. Bull., 46, 1339-1340, 1998.
67. Matsui T et al. In vitro survey of alpha-glucosidase inhibitory food components. Biosci. Biotech. Biochem., 60(12), 2019-2022, 1996.
68. Matsui T et al. Alpha-glucosidase inhibitory action of natural acylated anthocyanins. 1. Survey of natural pigments with potent inhibitory activity. J. Agric. Food Chem., 49(4), 1948-1951, 2001a.
69. Matsui T et al. Alpha-glucosidase inhibitory action of natural acylated anthocyanins. 2. alpha-glucosidase inhibitory action of natural acylated anthocyanins. J. Agric. Food Chem., 49(4), 1952-1956, 2001b.
70. Matsumoto K et al. Assay of α-glucosidase inhibitory activity using flow-biosensor. Anal. Chim. Acta, 479(2), 135-141, 2003.
71. Meir P and Yaniv Z. An in vitro study on the effect of Momordica charantia on glucose uptake and glucose metabolism in rats. Planta Med., 3, 12-16, 1985.
72. Mitsumoto Y et al. Differential expression of the GLUT1 and GLUT glucose transporters during differentiation of L6 muscle cells. Biochem. Biophys. Res. Commun., 175(2), 652-659, 1991.
73. Neef H et al. Inhibitory effects of Galega officinalis on glucose transport across a monolayer of human intestinal epithelial cells (Caco-2). Pharm. Pharamcol. Lett., 6, 86-89, 1996.
74. Newgard C et al. Studies on the mechanism by which exogenous glucose is converted to liver glycogen in the rat. J Biol Chem., 258, 8053-8059, 1983.
75. Ng TB et al. Insulin-like molecules in Momordica charantia seeds. J. Ethnopharmacol., 15, 107-117, 1986.
76. Nishioka T, Kawabata J and Aoyama Y. Baicalein, an α-glucosidase inhibitor from Scutellaria baicalensis. J. Nat. Prod., 61, 1413-1415, 1998.
77. Noor H, Hammonds P and Ashcroft S. The hypoglycemic and insulinotropic activity of Tinospora crispa. Studies with human and rat islets and HIT-T15 B cells. Diabetologia, 32, 354-359, 1989.
78. Ntambi JM and Kim YC. Adipocyte differentiation and gene expression. J. Nutr., 130, 3122S-3126S, 2000.
79. Oki T, Matsui T and Matsumoto K. Evaluation of α-glucosidase inhibition by using an immobilized assay system. Biol. Pharm. Bull., 23, 1084-1087, 2000.
80. Okubo M, Fujita N, and Nagasaka Y. Insulin regulates glycogen-synthase activity and its gene expression in rat hepatoma H4IIE cells. Diabetes, 42, A167, 1993.
81. Perl M and Hikino H. Effect of some hypoglycemic glycans on glucose uptake and glucose metabolism by inverted intestinal fragments. Phytother. Res., 3, 207-208, 1989.
82. Persaud SJ. Pancreatic β-cell lines: their roles in β-cell research and diabetes therapy, in Advances in Molecular and Cell Biology, Volume 29. JAI Press Inc., CT, 1999.
83. Persaud SJ et al. Gymnema sylvestre stimulates insulin release in vitro by increased membrane permeability. J. Endocrinol., 163, 207-212, 1999.
84. Phillips R et al. Human intestinal goblet cells in monolayer culture: characterization of a mucus-secreting subclone derived from the HT29 colon adenocarcinoma cell line. Gastroenterology, 94, 1390-1403, 1988.
85. Poitout V, Olson L and Robertson R. Insulin secreting cell lines: classification, characteristics and potential applications. Diabetes Metab., 22, 7-14, 1996.
86. Plomp P et al. Stimulation of glycogen synthesis in hepatocytes by added amino acids is related to total intracellular content of amino acids. J. Biochem., 191, 237-243, 1990.
87. Purello F et al. Metformin enhances certain insulin action in cultured rat hepatoma cells. Diabetologia, 31, 385-389, 1988.
88. Raman A and Lau C. Antidiabetic properties and phytochemistry of Momordica charantia L. (Cucurbitaceae). Phytomedicine, 2(4), 349-362, 1996.
89. Rhabasa-Lhoret R and Chiasson JL. α-Glucosidase inhibitors, in International Textbook of Diabetes Mellitus (volume 1), 3rd ed, Defronzo RA, Ferrannini E, Keen H and Zimmet P (Eds). John Wiley & Sons Ltd, Chichester, U.K., 2004, 901-914.
90. Rinninger F et al. Extrapancreatic action of the sulfonylurea gliquidone: post-receptor effect on insulinstimulated glycogen synthesis in rat hepatocytes in primary culture. Diabetologia, 26, 462-465, 1984.
91. Rotshteyn Y and Zito SW. Application of modified in vitro screening procedure for identifying herbals possessing sulfonyl-urea-like activity. J. Ethnopharmacol., 93, 337-344, 2004.
92. Ruitton-Ugilienco RL. [Comparison of two methods of insulin determination: enzymun-test insulin (Boering) and 125I insulin RIA-KIT (bioMerieux) used as a reference] [French]. Ann Biologie Clinique., 39(5), 295-296, 1981.
93. Salhanick A, Chang C and Amatruda J. Hormone and substrate regulation of glycogen accumulation in primary cultures of rat hepatocytes. Biochem. J., 261, 985-992, 1989.
94. Shibib BA, Khan LA and Rahman R. Hypoglycemic activity of Coccinia indica dn Momordica charantia in diabetic rats: depression of the hepatic gluconeogenic enzymes glucose-6-phosphatase and fructose-1,6-bisphosphatase and elevation of both liver and red-cell shunt enzyme glucose-6-phosphate dehydrogenase. Biochem. J., 292, 267-270, 1993.
95. Shimizu K et al. Structure-activity relationships of triterpenoid derivatives extracted from Gymnema inodorum leaves on glucose absorption. Jpn. J. Pharmacol., 86(2), 223-229, 2001.
96. Sitaswad SL, Shewade Y and Bhonde R. Role of bittergourd fruit juice in STZ-induced diabetic state in vivo and in vitro. J. Ethnopharmacol., 73, 71-79, 2000.
97. Smith RA et al. Isolation of glucagon antagonists by random momlecular mutagenesis and screening. Mol. Pharmacol., 43(5), 741-748, 1993.
98. Solling H and Esmann V. A sensitive method of glycogen determination in the presence of interfering substances using the filter-paper technique. Anal. Biochem., 68, 668, 1975.
99. Srijayanta S et al. In vitro screening of medicinal plants for potential antidiabetic effects. J. Pharm. Pharmacol., 50(S), 219, 1998.
100. Srijayanta S et al. Mangiferin, an antidiabetic compound from Anemarrhena asphodeloides. J. Pharm. Pharmacol., 51(S), 98, 1999.
101. Suzuki Y and Hikino H. Mechanism of hypoglycemic activity of panaxan A and B, glycans of Panax ginseng: effects on plasma level, secretion, sensitivity and binding of insulin in mice. Phytother. Res., 3, 20-24, 1989a.
102. Suzuki Y and Hikino H. Mechanism of hypoglycemic activity of panaxan A and B, glycans of Panax ginseng: effects on key enzymes of glucose metabolism in the liver of mice. Phytother. Res., 3, 15-19, 1989b.
103. Thorens, B. Glucose transporters in the regulation of intestinal, renal and liver glucose fluxes (review). Am. J. Physiol., 270, (Gastrointest., Liver. Physiol. 33), G541-G553, 1996.
104. Tosh D, Beresford G and Agius L. Glycogen synthesis from glucose by direct and indirect pathways in hepatocyte cultures form different nutritional states. Biochim. Biophys. Acta., 1224, 205-212, 1994.
105. Tremblay F, Dubois MJ and Marette A. Regulation of GLUT4 traffic and function by insulin and contraction in skeletal muscle. Frontiers Biosci., 8, D1072-D1084, 2003.
106. Valentova K et al. The effect of Smallanthus sonchifolius leaf extracts on rat hepatic metabolism. Cell Biol. Toxicol., 20(2), 109-120, 2004.
107. Valera A and Bosch F. Glucokinase expression in rat hepatoma cells induces glucose uptake and is rate limiting in glucose utilization. Eur. J. Biochem., 222(2), 533-539, 1994.
108. Vedavanam K et al. Antioxidant action and potential antidiabetic properties of an isoflavonoid-containing soyabean phytochemical extract (SPE). Phytother. Res., 13, 601-608, 1999.
109. Verspohl EJ. Recommended testing in diabetes research. Planta Med., 68, 581-590, 2002.
110. Vu L et al. Short-term insulin-induced glycogen formation in primary hepatocytes as a screening bioassay for insulin action. Anal. Biochem., 262, 17-22, 1998.
111. Wall ME et al. Effect of tannins on screening of plant extracts for their enzyme inhibitory activities and techniques for their removal. Phytomedicine, 3(4), 281-285, 1996.
112. Welihinda J and Karunanayake EH. Extrapancreatic effects of Momordica charantia in rats. J. Ethnopharmacol., 17, 247-255, 1986.
113. Wikman A et al. A drug absorption model based on the mucus layer producing human intestinal goblet cell line HT29-H. Pharm. Res., 9410, 843-850, 1993.
114. Wong CM, Ng TB and Yeung HW. Screening of Trichosanthes kirilowii, Momordica charantia and Cucurbita maxima (family Cucurbitaceae) for compounds with antilipolytic activity. J. Ethnopharmacol., 13, 313-321, 1985.
115. Wood C and Lawrence MJ. Models for intestinal drug absorption. J. Biopharm. Sci., 2, 147-172, 1991.
116. Yoshikawa M, Marakami T and Matsuda H. Medicinal foodstuffs. X. Structures of new triterpene glycosides, gymnemosides -c, -c, -e, and -f, from the leaves of Gymnema sylvestre R. Br: influence of gymnema glycosides on glucose uptake in rat small intestinal fragments. Chem. Pharm. Bull., 45(12), 2034-2038, 1997.
117. Yoshikawa M et al. Kotalanol, a potent α-glucosidase inhibitor with thiosugar sulfonium sulfate structure, from antidiabetic Ayurvedic medicine, Salacia reticulata. Chem. Pharm. Bull., 46, 1339-1340, 1998a.
118. Yoshikawa M et al. Antidiabetic principles of natural medicines II. Aldose reductase and α-glucosidase inhibitors from Brazilian natural medicines, the leaves of Myrcia multiflora DC (Myrtaceae). Structure of myrciacitrins I and II and myrciaphenones A and B. Chem. Pharm. Bull., 46, 113-119, 1998b.
119. Yoshikawa M et al. Salacia reticulata and its polyphenolic constituents with lipase inhibitory and lipolytic activity have mild antiobesity effects in rats. J. Nutr., 132(7), 1819-1824, 2002.
120. Zhang B et al. Discovery of a small molecule insulin mimetic with antidiabetic activity in mice. Science, 284, 974-977, 1999.